The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
Subscribe To Our Newsletter & Stay Updated
